Independent trial results expected for
November 2020
MONTREAL, Oct. 8, 2020 /CNW Telbec/ - Imaflex Inc.
("Imaflex" or the "Corporation") (TSXV: IFX), announces that the
ADVASEAL® Release Study is underway.
"The positive results for our recently announced Efficacy Trial
permits us to proceed with the last and most comprehensive study
required for the U.S. Environmental Protection Agency (EPA)
registration package," said Mr. Joe
Abbandonato, President and Chief Executive Officer of
Imaflex. The Release Study will determine the exact timing
each chemical is released into the soil from ADVASEAL®. This
is required to show compliance with the pre-harvest interval
established by the EPA, which is essentially the wait time required
between the last application of crop protection products and when a
crop can be harvested for safe human consumption.
"We expect that the independent trial results for the Release
Study will be available in November 2020. This should allow
us to submit the EPA registration package around year-end
2020." The EPA review process can take anywhere up to a year
to complete.
About ADVASEAL®
Today, agricultural films
are used in the growing of vegetables worldwide to cover soil
treated with fumigants – volatile and toxic pesticides essential
for reducing pests, weeds and fungi in the soil, thus supporting
good growth of new crop seedlings.
The original EPA approved ADVASEAL® (ADVASEAL® HSM), contained
only a herbicide for weed control. The new enhanced ADVASEAL®
(also called "ADVASEAL HG") under development also includes
fungicides and a nematicide to control soil borne pathogens, thus
becoming a complete non-fumigant alternative for soil
disinfestation. With ADVASEAL®, modern non-volatile crop
protection products can be applied more effectively and safely than
with fumigants. The crop protection products are incorporated
into a coating, which is then applied to a mulch film. Once
the coated film is applied to the ground, the active ingredients
are released into the soil under controlled conditions, preventing
the over/under-dosing found with current soil disinfestation
practices. This new technology dramatically reduces the
amount of crop protection products required. The catalyst to
trigger the release of the active ingredients is soil
moisture. When the film is applied to the soil, they are
efficiently and safely discharged into the ground, resulting in
heightened productivity, lower costs and notable environmental
benefits.
In September 2020, Imaflex
announced positive results for an Efficacy Trial.
ADVASEAL® was shown to be a viable soil fumigation alternative
to the current best grower practice of using fumigants to improve
yields of field grown vegetables. The independent report for
the Efficacy Trial can be found on the "Events and
Presentations" page of Imaflex's website at:
https://www.imaflex.com/English/news-and-events/events-and-presentations/.
About Imaflex Inc.
Founded in 1994, Imaflex is focused
on the development and manufacturing of innovative solutions for
the flexible packaging space. Concurrently, the Corporation
develops and manufactures films for the agriculture industry.
The Corporation's products consist primarily of polyethylene
(plastic) film and bags, including metalized plastic film, for the
industrial, agricultural and consumer markets. Headquartered
in Montreal, Quebec, Imaflex has
manufacturing facilities in Canada
and the United States. The Corporation's common stock is
listed on the TSX Venture Exchange under the ticker symbol
IFX. Additional information is available at
www.imaflex.com.
Cautionary Statement on Forward Looking
Information
Certain information included in this press
release constitutes "forward-looking" statements within the meaning
of Canadian securities laws. Forward-looking statements are
necessarily based upon a number of estimates and assumptions that,
while considered reasonable by the management of the Corporation,
are inherently subject to significant business, economic and
competitive uncertainties, risks and contingencies. The
Corporation cautions the reader that such forward-looking
statements involve known and unknown risks, uncertainties and other
factors that may cause the actual financial results, performance or
achievements of Imaflex to be materially different from the
Corporation's estimated future results, performance or achievements
expressed or implied by those forward-looking statements and that
the forward-looking statements are not guarantees of future
performance. These statements are also based on certain
factors and assumptions. For more details on these estimates,
risks, assumptions and factors, see the Corporation's most recent
Management Discussion and Analysis filed on SEDAR at www.sedar.com
and on the investor section of the Corporation's website at
www.imaflex.com. The Corporation disclaims any obligation to
update or revise any forward-looking statements, whether as a
result of new information, events or otherwise, except as expressly
required by law. Readers are cautioned not to put undue
reliance on these forward-looking statements.
Neither the TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
SOURCE Imaflex Inc.